Matthew Sperrin

Matthew Sperrin

Auto-generated profile, based on publicly available information

Matthew Sperrin

Division of informatics, Imaging and Data Science, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2016 in Current Oncology Reports
Verified
Journal Article
Open access
PDF file
HLHannah Lennon
Hannah Lennon
MSMatthew Sperrin
Matthew Sperrin
EBEllena Badrick
Ellena Badrick
ARAndrew G. Renehan
Andrew G. Renehan
There is a common perception that excess adiposity, commonly approximated by body mass index (BMI), is associated with reduced cancer survival. A number of studies have emerged challenging this by demonstrating that overweight and early obese states are associated with improved survival. This finding is termed the “obesity paradox” and is well recognized in the cardio-metabolic literature but less so in oncology. Here, we summarize the epidemiological findings related to the obesity paradox in cancer. Our review highlights that many observations of the obesity paradox in cancer reflect methodological mechanisms including the crudeness of BMI as an obesity measure, confounding, detection bias, reverse causality, and a specific form of the selection bias, known as collider bias. It is imperative for the oncologist to interpret the observation of the obesity paradox against the above methodological framework and avoid the misinterpretation that being obese might be “good” or “protective” for cancer patients.

7 July 2018 in BMJ Open
Verified
Journal Article
Open access
PDF file
HLHannah Lennon
Hannah Lennon
SKScott Kelly
Scott Kelly
MSMatthew Sperrin
Matthew Sperrin
Iain BuchanIain Buchan
Iain Buchan
ACAmanda J Cross
Amanda J Cross
ARAndrew G Renehan
Andrew G Renehan
Objectives Latent class trajectory modelling (LCTM) is a relatively new methodology in epidemiology to describe life-course exposures, which simplifies heterogeneous populations into homogeneous patterns or classes. However, for a given dataset, it is possible to derive scores of different models based on number of classes, model structure and trajectory property. Here, we rationalise a systematic framework to derive a ‘core’ favoured model. Methods We developed an eight-step framework: step 1: a scoping model; step 2: refining the number of classes; step 3: refining model structure (from fixed-effects through to a flexible random-effect specification); step 4: model adequacy assessment; step 5: graphical presentations; step 6: use of additional discrimination tools (‘degree of separation’; Elsensohn’s envelope of residual plots); step 7: clinical characterisation and plausibility; and step 8: sensitivity analysis. We illustrated these steps using data from the NIH-AARP cohort of repeated determinations of body mass index (BMI) at baseline (mean age: 62.5 years), and BMI derived by weight recall at ages 18, 35 and 50 years. Results From 288 993 participants, we derived a five-class model for each gender (men: 177 455; women: 111 538). From seven model structures, the favoured model was a proportional random quadratic structure (model F). Favourable properties were also noted for the unrestricted random quadratic structure (model G). However, class proportions varied considerably by model structure—concordance between models F and G were moderate (Cohen κ: men, 0.57; women, 0.65) but poor with other models. Model adequacy assessments, evaluations using discrimination tools, clinical plausibility and sensitivity analyses supported our model selection. Conclusion We propose a framework to construct and select a ‘core’ LCTM, which will facilitate generalisability of results in future studies.

6 January 2017 in BMC Medical Research Methodology
Verified
Journal Article
Open access
PDF file
GMGlen P. Martin
Glen P. Martin
MMMamas A. Mamas
Mamas A. Mamas
NPNiels Peek
Niels Peek
Iain BuchanIain Buchan
Iain Buchan
MSMatthew Sperrin
Matthew Sperrin
Clinical prediction models (CPMs) are increasingly deployed to support healthcare decisions but they are derived inconsistently, in part due to limited data. An emerging alternative is to aggregate existing CPMs developed for similar settings and outcomes. This simulation study aimed to investigate the impact of between-population-heterogeneity and sample size on aggregating existing CPMs in a defined population, compared with developing a model de novo. Simulations were designed to mimic a scenario in which multiple CPMs for a binary outcome had been derived in distinct, heterogeneous populations, with potentially different predictors available in each. We then generated a new ‘local’ population and compared the performance of CPMs developed for this population by aggregation, using stacked regression, principal component analysis or partial least squares, with redevelopment from scratch using backwards selection and penalised regression. While redevelopment approaches resulted in models that were miscalibrated for local datasets of less than 500 observations, model aggregation methods were well calibrated across all simulation scenarios. When the size of local data was less than 1000 observations and between-population-heterogeneity was small, aggregating existing CPMs gave better discrimination and had the lowest mean square error in the predicted risks compared with deriving a new model. Conversely, given greater than 1000 observations and significant between-population-heterogeneity, then redevelopment outperformed the aggregation approaches. In all other scenarios, both aggregation and de novo derivation resulted in similar predictive performance. This study demonstrates a pragmatic approach to contextualising CPMs to defined populations. When aiming to develop models in defined populations, modellers should consider existing CPMs, with aggregation approaches being a suitable modelling strategy particularly with sparse data on the local population.

3 May 2017 in European Journal of Heart Failure
Verified
Journal Article
Closed access
PDF file
MMMamas A. Mamas
Mamas A. Mamas
MSMatthew Sperrin
Matthew Sperrin
MWMargaret C. Watson
Margaret C. Watson
ACAlasdair Coutts
Alasdair Coutts
KWKatie Wilde
Katie Wilde
PMPhyo K. Myint
Phyo K. Myint

9 January 2017 in BMC Medical Research Methodology
Verified
Journal Article
Open access
PDF file
EKEvangelos HEATHER Kontopantelis
Evangelos HEATHER Kontopantelis
IWIan R. White
Ian R. White
MSMatthew Sperrin
Matthew Sperrin
Iain BuchanIain Buchan
Iain Buchan
Multiple imputation is frequently used to deal with missing data in healthcare research. Although it is known that the outcome should be included in the imputation model when imputing missing covariate values, it is not known whether it should be imputed. Similarly no clear recommendations exist on: the utility of incorporating a secondary outcome, if available, in the imputation model; the level of protection offered when data are missing not-at-random; the implications of the dataset size and missingness levels. We used realistic assumptions to generate thousands of datasets across a broad spectrum of contexts: three mechanisms of missingness (completely at random; at random; not at random); varying extents of missingness (20–80% missing data); and different sample sizes (1,000 or 10,000 cases). For each context we quantified the performance of a complete case analysis and seven multiple imputation methods which deleted cases with missing outcome before imputation, after imputation or not at all; included or did not include the outcome in the imputation models; and included or did not include a secondary outcome in the imputation models. Methods were compared on mean absolute error, bias, coverage and power over 1,000 datasets for each scenario. Overall, there was very little to separate multiple imputation methods which included the outcome in the imputation model. Even when missingness was quite extensive, all multiple imputation approaches performed well. Incorporating a secondary outcome, moderately correlated with the outcome of interest, made very little difference. The dataset size and the extent of missingness affected performance, as expected. Multiple imputation methods protected less well against missingness not at random, but did offer some protection. As long as the outcome is included in the imputation model, there are very small performance differences between the possible multiple imputation approaches: no outcome imputation, imputation or imputation and deletion. All informative covariates, even with very high levels of missingness, should be included in the multiple imputation model. Multiple imputation offers some protection against a simple missing not at random mechanism.

1 April 2015 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
BBBarbara K. Ballmer-Weber
Barbara K. Ballmer-Weber
MFMontserrat Fernandez-Rivas
Montserrat Fernandez-Rivas
KBKirsten Beyer
Kirsten Beyer
MDMarianne Defernez
Marianne Defernez
MSMatthew Sperrin
Matthew Sperrin
CMClare Mills
Clare Mills